个人简述:

李嘉宾，男，1972年8月生，副教授，硕士生导师。2006年博士毕业于中国药科大学药学院药物化学专业。2013-2014美加州大学圣芭芭拉分校化学与生物化学系访问学者。2015.3-2017.3期间担任江苏天士力帝益药业有限公司兼职科技副总，2017起担任华海药业海外基地工业药学专硕校内合作导师。主持江苏省自然科学基金面上项目1项、江苏省双创计划双创博士项目1项，参与国家863计划、国家自然科学基金等纵向课题3项，承担企业委托项目2项。在Chem Comm, Euro J Med Chem, J Mol Model等学术期刊发表研究性论文18篇（其中SCI源论文11篇，最高影响因子6.718），申请专利6项，授权2项。指导和协助指导研究生15人，已毕业5人。

科研工作:

已发表主要研究性论文：(1) Jiabin Li, Kegong Ji, Renhua Zheng, Jonathan Nelson, Liming Zhang*Expanding the horizon of intermolecular trapping of in situ generated α-oxo gold carbenes: efficient oxidative union of allylic sulfides and terminal alkynes via C–C bond formationChem. Commun., 2014, 50, 4130-4133DOI: 10.1039/C4CC00739E(SCI IF: 6.718)(2) Yaping Song, Zhengyuan Xin, Yumeng Wan, Jiabin Li, Boping Ye, Xiaowen Xue* “Synthesis and anticancer activity of some novel indolo[3,2-b] andrographolide derivatives as apoptosis-inducing agents” Euro. J. Med. Chem., 2015, 90C(12): 695-706 (SCI IF: 3.432)(3) Jun Xia, Jiabin Li*, Hongbin Sun* Insights into ETA subtype selectivity of benzodiazepine endothelin receptor antagonists by 3D-QSAR approachesJ. Mol. Model, 2012, 18(4): 1299-1322, DOI 10.1007/s00894-011-1153-x (SCI IF: 1.982)(4) Lutai Wang, Jiabin Li, Xiaowen Xue*A concise synthesis of ximenynic acidSynth. Commun. 2012, 42, 3540-3543, DOI 10.1080/00397911.2011.585443 (SCI IF: 1.060)(5) Jiabin Li, HaichunLiu, Li Zhang, Tao Wang, Zhenzhou Jjiang, Lin Xia*,Searching for the novel lead compounds of α1-AR antagonists (Part II): synthesis, bioassays and 3D-QSAR of 2-(4-(Aryloxyalkyl)-piperazin-1-yl)benzo[d]oxazole compounds Chem. J. Chinese U., 2009, 30(5): 903-907(SCI IF: 0.937)